By Wholesale Lab Peptides · Published · Research procurement guide
Start with what the test actually measures.
Bacterial endotoxin testing concerns endotoxins from Gram-negative bacteria. USP’s Chapter 86 preview describes tests that detect or quantify them using recombinant Factor C or recombinant cascade reagents. Read USP’s primary chapter preview.
That is a different measurement from peptide identity or chromatographic purity. Keep an endotoxin result on its own line in the procurement record. Do not infer it from a purity percentage or replace an identity check with an endotoxin certificate.
This guide is about reviewing research-supply documentation. It does not establish sterility, suitability for administration, a universal acceptance limit or a testing claim for our offered batches. Ask which records exist for your selected specification.
Match the sample to the proposed order.
For a BPC-157 order, ask which BPC-157 lot the laboratory sampled. For GHK-Cu, retain the complete copper-complex identity. For Semax or Selank, identify whether the tested sample was the material itself or a specified finished presentation. The peptide name is only the first matching field.
Record the report reference, sample identifier, lot number, physical form and supplied configuration. Compare them with the quote and proposed batch records. If a laboratory report uses a different sample code, request the link between that code and the offered lot.
Wholesale amounts and available formats are confirmed during enquiry. Review the accepted specification rather than importing a strength from another catalogue. The COA checklist covers the broader batch-document reconciliation.
Build a short, specific report checklist.
| Field | Request or record | Question to resolve |
|---|---|---|
| Tested sample | Material, lot, sample reference and presentation | Is this the offered batch and configuration? |
| Method | Procedure reference, version and reagent approach | Which assay produced the result? |
| Suitability | Applicable product-specific supporting record | Was the method evaluated for this sample? |
| Result | Reported value or bound and its units | What exactly does the number represent? |
| Acceptance | Agreed limit on the same reporting basis | Who established the criterion and for what specification? |
| Exceptions | Missing fields, deviations and reviewer response | What remains open before acceptance? |
Use the table as an enquiry sheet, not as a certificate template. Preserve the laboratory’s wording and ask for clarification when a field cannot be matched. A blank field should remain visible until someone supplies the answer.
A method name needs supporting context.
The FDA’s March 2026 Edition 2 guidance discusses bacterial endotoxin testing for regulated drugs, biological products and devices. It notes that sample handling can affect detection and that product ingredients can interfere with an assay. Read FDA guidance, questions 3 and 12.
For your document review, ask the laboratory which supporting record demonstrates suitability for the actual sample. Identify the method and version before comparing reports from different dates. Do not select a laboratory dilution or assay procedure from a marketing page; the technical laboratory should explain the conditions used.
The USP Chapter 86 preview describes nonanimal-derived reagent approaches, including rFC and rCR. See the recombinant-reagent descriptions. Those labels identify an assay approach; they do not, by themselves, establish that an offered peptide lot has been tested.
These references explain terminology. They do not certify our products or establish which regulatory provisions apply to a buyer’s project.
Read the value, bound and units together.
Copy the result exactly before summarising it. A figure expressed per millilitre should not be compared directly with one expressed per mass or per unit. Ask for the reporting basis and any conversion supplied by the laboratory; retain the assumptions alongside it.
A result reported below a stated boundary is a bounded result. Keep the boundary in the purchasing record rather than rewriting the entry as zero. Likewise, a “pass” statement is easier to assess when the report shows the applicable criterion and the measurement behind it.
Agree the acceptance criterion with the responsible technical reviewer before using it to approve an order. This page supplies no numerical limit: the named material, presentation, intended research context and accepted specification need their own review.
Keep presentation and other tests separate.
A vial report is not automatically a report for every component of a pen-style kit. Ask what was sampled and which configuration the record covers. For an OEM or private-label project, preserve that scope beside the agreed packaging revision.
Maintain separate entries for any identity, purity, content, endotoxin and other microbiological records requested. A general phrase such as “lab tested” does not tell the buyer which entries are complete. Our purity and content guide explains those analytical distinctions.
The vial and kit checklist helps define the configuration. If a time-based evidence question remains, use the separate stability-report guide.
Request the missing evidence by name.
Send the named peptides, quantities by variant, proposed presentation and destination in the USA, Canada or Australia. Request the available batch-specific endotoxin documents and ask the team to identify gaps. Include the accepted content and reporting basis so the request can be reconciled with the quote.
For example, ask “Which report covers the proposed GHK-Cu lot and what are its result units?” rather than “Do you have all certificates?” A focused question produces a record you can compare and leaves unresolved details visible.
Request endotoxin documentationExplore the wholesale catalogue, contact our supply team or email sales@wholesalelabpeptides.com for current availability and dispatch options.